It might be simple, or it might not be.
The simple - they didn't hit the profit they projected during the last qrt due to varying - hopefully one-off - reasons. The market dont like it when you fail to meet expectations and dont paint an ultra rosey picture moving forward.
(Also, making an official announcement to the market regarding some gossip that was blurted out on HC by a disgruntled ex-employee was an amateurish move)
The not so simple - is there something deeper going on? Did they pay too much for the acquisition? Will it cost too much to explore overseas? Is the increase in R&D expenditure a scope into their product's needing to be more dynamic?
Even with these issues, I still think it's a solid company with good fundamentals. I will be holding long-term 5+ years (Unless something drastic happens) and even bought more recently at these cheaper prices. PLUS im a part of the DRP, so I will also increase my holdings over the next few years via this avenue.
- Forums
- ASX - By Stock
- LBL
- Ann: Investor Presentation
LBL
laserbond limited
Add to My Watchlist
0.00%
!
36.0¢

Ann: Investor Presentation, page-49
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.35M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 36.0¢ | $219.3K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 18685 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 0.360 |
5 | 79787 | 0.355 |
2 | 10132 | 0.350 |
2 | 30030 | 0.345 |
6 | 21741 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 14354 | 1 |
0.370 | 11746 | 2 |
0.380 | 75000 | 2 |
0.385 | 60000 | 2 |
0.390 | 43000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LBL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online